Neoadjuvant Chemotherapy in Operable Breast Cancer: The Pros

Publisher： Karger

E-ISSN： 1661-3805|1|6|348-351

ISSN： 1661-3791

Source： Breast Care, Vol.1, Iss.6, 2006-12, pp. : 348-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pathological Workup of Surgical Breast Cancer Specimens after Neoadjuvant Chemotherapy

By  

Breast Care, Vol. 1, Iss. 6, 2006-12 ,pp. : 368-373

Karger

Access to resources Recommend Favorite

Neoadjuvant Dose-Dense and Dose-Intensified Chemotherapy in Breast Cancer - Review of the Literature

By  

Breast Care, Vol. 11, Iss. 1, 2016-02 ,pp. : 13-20

Karger

Access to resources Recommend Favorite

Effectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report

By  

Breast Care, Vol. 12, Iss. 1, 2017-02 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - a Prospective Clinical Study

By  

Breast Care, Vol. 12, Iss. 3, 2017-06 ,pp. : 160-164

Karger

Access to resources Recommend Favorite

Neoadjuvant Treatment with Taxanes in Breast Cancer

By  

Breast Care, Vol. 1, Iss. 3, 2006-07 ,pp. : 176-184

Karger

Access to resources Recommend Favorite